Literature DB >> 15336958

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature).

Ingo Marenholz1, Claus W Heizmann, Günter Fritz.   

Abstract

The S100 protein family is the largest subgroup within the superfamily of proteins carrying the Ca2+-binding EF-hand motif. Despite their small molecular size and their conserved functional domain of two distinct EF-hands, S100 proteins developed a plethora of tissue-specific intra- and extracellular functions. Accordingly, various diseases such as cardiomyopathies, neurodegenerative and inflammatory disorders, and cancer are associated with altered S100 protein levels. Here, we review the different S100 protein functions and related diseases from an evolutionary point of view. We analyzed the structural variations, which are the basis of functional diversification, as well as the genomic organization of the S100 family in human and compared it with the S100 repertoires in mouse and rat. S100 genes and proteins are highly conserved between the different mammalian species. Moreover, we identified evolutionary related subgroups of S100 proteins within the three species, which share functional similarity and form subclusters on the genomic level. The available S100-specific mouse models are summarized and the consequences of our results are discussed with regard to the use of genetically engineered mice as human disease models. An update of the S100 nomenclature is included, because some of the recently identified S100 genes and pseudogenes had to be renamed. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336958     DOI: 10.1016/j.bbrc.2004.07.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  264 in total

1.  Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.

Authors:  Ronan S Rogers; Moyez Dharsee; Suzanne Ackloo; Jeremy M Sivak; John G Flanagan
Journal:  Mol Cell Proteomics       Date:  2011-11-29       Impact factor: 5.911

2.  Crystal structure of the S100A4-nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism.

Authors:  Bence Kiss; Annette Duelli; László Radnai; Katalin A Kékesi; Gergely Katona; László Nyitray
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-28       Impact factor: 11.205

3.  The calcium-dependent interaction between S100B and the mitochondrial AAA ATPase ATAD3A and the role of this complex in the cytoplasmic processing of ATAD3A.

Authors:  Benoît Gilquin; Brian R Cannon; Arnaud Hubstenberger; Boualem Moulouel; Elin Falk; Nicolas Merle; Nicole Assard; Sylvie Kieffer; Denis Rousseau; Paul T Wilder; David J Weber; Jacques Baudier
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

4.  S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

Authors:  Fei Zhao; Bastian Hoechst; Austin Duffy; Jaba Gamrekelashvili; Suzanne Fioravanti; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

5.  Loss of S100 antigenicity in metastatic melanoma.

Authors:  Dara L Aisner; Ajay Maker; Steven A Rosenberg; David M Berman
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

6.  Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes.

Authors:  D Han; X Cai; J Wen; D Matheson; J S Skyler; N S Kenyon; Z Chen
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

7.  Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression.

Authors:  Rohan Dhiman; Sambasivan Venkatasubramanian; Padmaja Paidipally; Peter F Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

8.  Purification and crystallization of the human EF-hand tumour suppressor protein S100A2.

Authors:  Michael Koch; Joachim Diez; Günter Fritz
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-20

Review 9.  The evolution of S100B inhibitors for the treatment of malignant melanoma.

Authors:  Kira G Hartman; Laura E McKnight; Melissa A Liriano; David J Weber
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

10.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.